Thorne, a supplement brand recently taken private by L Catterton, is on track to achieve $650 million in annual revenue, driven by a significant uptick in sales among Gen Z and millennial consumers. The company has experienced a compound annual growth rate exceeding 30% since its acquisition, with revenue projected to more than double from $229 million in 2022 to over $500 million by 2025. This growth is fueled by a shift in consumer behavior, with younger shoppers increasingly prioritizing health optimization over traditional preventative measures.
The booming vitamins, minerals, and supplements market, expected to reach $125 billion in the U.S. by 2025, presents substantial opportunities for Thorne and its competitors. With around 60% of its revenue coming from consumers under 40, Thorne is tapping into a demographic that is willing to spend significantly more on wellness products. The brand’s strategic focus on direct-to-consumer sales, alongside a disciplined pricing strategy, positions it well within a rapidly evolving market landscape.
As health-conscious younger consumers reshape the supplement industry, Thorne’s growth trajectory indicates a potential for further expansion, possibly leading to an IPO or strategic acquisition in the future. Market professionals should monitor Thorne’s performance and consumer engagement strategies as indicators of broader trends in the health and wellness sector.
Source: cnbc.com